DGAP-Adhoc

LifeWatch AG: Agreement signed to utilize Vital Connect Inc.'s HealthPatch(R) MD in its cardiac monitoring business

LifeWatch AG / Key word(s): Alliance

07.11.2014 21:15

Release of an ad hoc announcement pursuant to Art. 53 KR
---------------------------------------------------------------------------

LifeWatch AG signs agreement to utilize Vital Connect Inc.'s HealthPatch(R)
MD in its cardiac monitoring business

Neuhausen am Rheinfall/Switzerland, November 7, 2014 - LifeWatch AG (SIX
Swiss Exchange: LIFE), a leading provider of medical solutions in remote
cardiac monitoring, is pleased to announce the signing of an agreement with
Vital Connect Inc. to utilize their HealthPatch MD as a 1-lead ECG device
in its cardiac monitoring business.

LifeWatch and Vital Connect are working together to integrate the
HealthPatch MD into LifeWatch's analytical mobile application and reporting
systems with a view to bringing an integrated solution to market in the
first half of 2015.

This move follows on the heels of the development of LifeWatch's already
announced Vital Signs Patch (VSP) which is also due for release in the
first half of 2015. Dr. Stephan Rietiker, CEO of LifeWatch, noted: "I am
very excited about the new partnership as it comprises a breakthrough
technology that will enable LifeWatch to expand its cardiac monitoring
device offerings for patients to include the important patch technology
area." Patch technology is easy to use and should increase the
effectiveness of cardiac monitoring due to higher patient compliance.

Vital Connect Inc.'s HealthPatch MD biosensor for monitoring patients
received FDA clearance for home use in July 2014 and, as a result of its
weight and thickness (only 10 g and 6 mm (0.24"), respectively), offers
patients a much more comfortable and less obtrusive monitoring solution in
comparison to conventional monitoring equipment.


For further questions:

LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: [phone]
E-mail: [e-mail] About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX
Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced telehealth systems and wireless remote patient
monitoring services. LifeWatch's services provide physicians with critical
information to determine appropriate treatment and thereby improve patient
outcomes. LifeWatch AG has operative subsidiaries in the United States, in
Switzerland and in Israel, and is the parent company of LifeWatch Services
Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a
leading U.S.-based provider of cardiac monitoring services and home sleep
testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd.,